Boston Scientific (MEX:BSX) Tariff Resilience Score: 5/10 (As of Jul. 08, 2026)


MEX:BSX Boston Scientific Corp MEX:BSX
85 GF Score
Price MXN795.01
GF Value MXN1,852.02
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Boston Scientific Tariff Resilience Score?

Boston Scientific MEX:BSX +1.40% 85 Tariff Resilience Score is 5 as of Jul. 08, 2026. GuruFocus rates MEX:BSX with a GF Score™ of 85/100 and a GF Value™ of MXN1,852.02 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 836 Medical Devices & Instruments companies, Boston Scientific ranks better than 79.19% on this metric.

Boston Scientific has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Boston Scientific has Boston Scientific has a global supply chain and sales markets, exposing it to tariff risks. While it can leverage its scale and pricing power, its reliance on imported components for medical devices makes it moderately vulnerable to tariffs.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Boston Scientific might have Average Resilient.

Boston Scientific  (MEX:BSX) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Boston Scientific Tariff Resilience Score Related Terms

MEX:BSX vs EW, GEHC, MDT: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Boston Scientific's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boston Scientific Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Tariff Resilience Score falls into.


MEX:BSX
85GF Score
Boston Scientific Corp MEX:BSX
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Boston Scientific (MEX:BSX) has a Tariff Resilience Score of 5 as of Jul. 08, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Boston Scientific ranks #174 out of 836 companies in the Medical Devices & Instruments industry, placing it in the top 20.8%.
Is Boston Scientific's Tariff Resilience Score too high?
Boston Scientific's current Tariff Resilience Score is 5. Based on the distribution chart, Boston Scientific ranks #174 out of 836 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Boston Scientific has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Tariff Resilience Score compare to EW and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Boston Scientific ranks #174 out of 836 companies for Tariff Resilience Score. This places Boston Scientific in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Boston Scientific's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (MEX:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,852.02, compared to a current price of MXN795.01 — trading 57.1% below its estimated fair value. The current Tariff Resilience Score is 5. Boston Scientific's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Boston Scientific (MEX:BSX), the current Tariff Resilience Score is 5 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boston Scientific (MEX:BSX) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of MXN795.01 is trading 57.1% below its estimated GF Value™ of MXN1,852.02. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for MEX:BSX:

  • Tariff Resilience Score: 5
  • GF Value™: MXN1,852.02 vs. price of MXN795.01 (57.1% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
85GF Score

Get the complete analysis for MEX:BSX

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN795.01
Price
MXN1,852.02
GF Value